Clinical digest. Immunity of breast cancer patients compromised months after chemotherapy treatmentAn of the research article "Lymphocyte Depletion and Repopulation after Chemotherapy for Primary Breast Cancer," by V. Rashmi et. al which appeared in the journal "Breast Cancer Research" is presented...
A cost benefit associated with the use of filgrastim in patients with breast cancer has been realised. This may lead to a re-evaluation of the current treatment guidelines.doi:10.2165/00003495-200262001-00002FrasciGiuseppeSpringer International PublishingDrugs...
The side effects a breast cancer patient experiences while undergoing chemotherapy vary significantly depending on several factors, including the types of drugs used, their dosages, and the duration of treatment. This section discusses some of the possible side effects that breast cancer patients may ...
The experiences of a cohort of 60 women receiving chemotherapy in treatment of breast cancer were monitored in an in-depth prospective study. The purpose of the investigation was to identify ways in which nurses could improve the preparation and support of patients undergoing chemotherapy. It was ...
one day after the initial chemotherapy treatment6. However, serial expression analyses of breast tumors from patients receiving neoadjuvant chemotherapies (NAC) in the I-SPY 1 trial presented contradictory evidence, revealing downregulation of immune genes after 1–4 days of chemotherapy treatment7. ...
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, according to a new study from researchers at The University of Texas MD And...
Chemotherapy is associated with an increased risk of treatment-related heart damage, including heart failure and cerebrovascular disease, for many patients. But a new meta-analysis, presented at the American College of Cardiology's Advancing the Cardiova
McLachlan S-A, Devins GM, Goodwin PJ: Validation of the European Organization for Research and Treatment of Cancer quality of life questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. Eur J Cancer 34: 510–516, 1998 Google Scholar Breervelt IS, Van Dam ...
Objective To compare time to cancer treatment initiation and relative dose intensity (RDI) of neoadjuvant and adjuvant chemotherapy among patients with breast cancer with vs without HIV. Design, Setting, and Participants A retrospective, matched cohort study enrolled women who received a diagnos...
Preoperative chemotherapy using a sequential or simultaneous combination of anthracycline and taxane anticancer drugs has spread as a standard therapy in breast cancer patients who biologically require perioperative chemotherapy, mainly for the purpose of down staging (reduction of local therapy: breast-conse...